Company
Headquarters: New Taipei City, Taiwan
Employees: 163
TW$1.44 Billion
TWD as of Jan. 1, 2024
US$47.1 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry. The company provides food safety and Covid-19 diagnostic testing products. It also offers abused drugs rapid tests; and operates drug testing center for urine drug test, hair drug test, and identification of drug abuse. In addition, the company develops Hb4Cord to treat hematopoietic and genetic diseases; and provides cell banking services. Taiwan Advance Bio-Pharmaceutical Inc. was founded in 1989 and is based in New Taipei City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Taiwan Advance Bio-Pharmaceutical, Inc. has the following listings and related stock indices.
Stock: TWSE: 4186 wb_incandescent